Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Pregnancy and Childbirth
Published in: BMC Pregnancy and Childbirth 1/2018

Open Access 01-12-2018 | Research article

A comparison of misoprostol vaginal insert and misoprostol vaginal tablets for induction of labor in nulliparous women: a retrospective cohort study

Authors: Kjersti Engen Marsdal, Ingvil Krarup Sørbye, Lise C. Gaudernack, Mirjam Lukasse

Published in: BMC Pregnancy and Childbirth | Issue 1/2018

Login to get access

Abstract

Background

Since Misoprostol Vaginal Insert (MVI - Misodel ®) was approved for labor induction in Europe in 2013, to date, no study has been published comparing MVI to Misoprostol vaginal tablets (MVT). The aim of this study, performed as part of a quality improvement project, was to compare the efficacy and safety of 200 μg MVI versus 25 μg MVT for labor induction in nulliparous women.

Methods

This retrospective cohort study included 171 nulliparous singleton term deliveries induced with MVI (n = 85) versus MVT (n = 86) at Oslo University Hospital Rikshospitalet, Norway, from November 2014 to December 2015. Primary outcomes were time from drug administration to delivery in hours and minutes and the rate of cesarean section (CS). Results were adjusted for Bishop Score and pre-induction with balloon catheter.

Results

Median time from drug administration to delivery was shorter in the MVI group compared to the MVT group (15 h 43 min versus 19 h 37 min, p = 0.011). Adjusted for confounding factors, mean difference was 6 h 3 min (p = 0.002). The risk of CS was 67% lower in the MVI group compared to the MVT group (11.8% versus 23.3%, OR = 0.33; adjusted 95% CI 0.13–0.81). Adverse neonatal outcomes did not differ between the groups.

Conclusions

In a setting of routine obstetric care, MVI seems to be a more efficient labor induction agent than MVT, and with a lower CS rate and no increase in adverse infant outcomes.
Literature
1.
2.
Dögl M, Vanky E, Heimstad R. Changes in induction methods have not influenced cesarean section rates among women with induced labor. Acta Obstet Gynecol Scand. 2016;95(1):112–5.CrossRefPubMed
3.
Yeast JD, Jones A, Poskin M. Induction of labor and the relationship to cesarean delivery: a review of 7001 consecutive inductions. Am J Obstet Gynecol. 1999;180(3 Pt 1):628–33.CrossRefPubMed
4.
Vahratian A, Zhang J, Troendle JF, Sciscione AC, Hoffman MK. Labor progression and risk of cesarean delivery in electively induced nulliparas. Obstet Gynecol. 2005;105(4):698–704.CrossRefPubMed
5.
Stewart RD, Bleich AT, Lo JY, Alexander JM, McIntire DD, Leveno KJ. Defining uterine tachysystole: how much is too much? Am J Obstet Gynecol. 2012;207(4):290–6.CrossRefPubMed
6.
Kolås T, Hofoss D, Daltveit AK, Nilsen ST, Henriksen T, Häger R, Ingemarsson I, Øian P. Indications for cesarean deliveries in Norway. Am J Obstet Gynecol. 2003;188(4):864–70.CrossRefPubMed
7.
Hofmeyr GJ, Gülmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2010;10
8.
9.
10.
Wing DA, Brown R, Plante LA, Miller H, Rugarn O, Powers BL. Misoprostol vaginal insert and time to vaginal delivery: a randomized controlled trial. Obstet Gynecol. 2013;122(2 Pt 1):201–9.CrossRefPubMed
11.
Mayer RB, Oppelt P, Shebl O, Pömer J, Allerstorfer C, Weiss C. Initial clinical experience with a misoprostol vaginal insert in comparison with a dinoprostone insert for inducing labor. Eur J Obstet Gynecol Reprod Biol. 2016;200:89–93.CrossRefPubMed
12.
Dobert M, Brandstetter A, Henrich W, Rawnaq T, Hasselbeck H, Dobert TF, Hinkson L, Schwaerzler P. The misoprostol vaginal insert compared with oral misoprostol for labor induction in term pregnancies: a pair-matched case-control study. J of. Perinat Med. 2017;
13.
Gornisiewicz T, Jaworowski A, Zembala-Szczerba M, Babczyk D, Huras H. Analysis of intravaginal misoprostol 0.2 mg versus intracervical dinoprostone 0.5 mg doses for labor induction at term pregnancies. Ginekologia pol. 2017;88(6):320–4.CrossRef
14.
Robson M, Murphy M, Byrne F. Quality assurance: the 10-group classification system (Robson classification), induction of labor, and cesarean delivery. Int J Gynaecol Obstet. 2015;131:23–7.CrossRef
15.
Pevzner L, Rayburn WF, Rumney P, Wing DA. Factors predicting successful labor induction with dinoprostone and misoprostol vaginal inserts. Obstet Gynecol. 2009;114(2 Pt 1):261–7.CrossRefPubMed
16.
Wing DA, Tran S, Paul RH. Factors affecting the likelihood of successful induction after intravaginal misoprostol application for cervical ripening and labor induction. Am J Obstet Gynecol. 2002;186(6):1237–40.CrossRefPubMed
17.
Crane JMG, Delaney T, Butt KD, Bennett KA, Hutchens D, Young DC. Predictors of successful labor induction with oral or vaginal misoprostol. J Matern Fetal Med. 2004;15(5):319–23.CrossRef
18.
Chen W, Xue J, Gaudet L, Walker M, Wen SW. Meta-analysis of Foley catheter plus misoprostol versus misoprostol alone for cervical ripening. Int J Gynaecol Obstet. 2015;129(3):193–8.CrossRefPubMed
19.
Laughon SK, Berghella V, Reddy UM, Sundaram R, Lu Z, Hoffman MK. Neonatal and maternal outcomes with prolonged second stage of labor. Obstet Gynecol. 2014;124(1):57–67.CrossRefPubMedPubMedCentral
20.
Maghoma J, Buchmann EJ. Maternal and fetal risks associated with prolonged latent phase of labour. J Obstet Gynaecol. 2002;22(1):16–9.CrossRefPubMed
21.
Wing DA, Miller H, Parker L, Powers BL, Rayburn WF. Misoprostol vaginal insert for successful labor induction: a randomized controlled trial. Obstet Gynecol. 2011;117(3):533–41.CrossRefPubMed
22.
Gregson S, Waterstone M, Norman I, Murrells TA. Randomised controlled trial comparing low dose vaginal misoprostol and dinoprostone vaginal gel for inducing labour at term. BJOG. 2005;112(4):438–44.CrossRefPubMed
23.
Calder AA, Loughney AD, Weir CJ, Barber JW. Induction of labour in nulliparous and multiparous women: a UK, multicentre, open-label study of intravaginal misoprostol in comparison with dinoprostone. BJOG. 2008;115(10):1279–88.CrossRefPubMed
24.
Wing DA, Ham D, Paul RHA. Comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction. Am J Obstet Gynecol. 1999;180(5):1155–60.CrossRefPubMed
25.
van Gemund N, Scherjon S, LeCessie S, van Leeuwen JHS, van Roosmalen J, Kanhai HHH. A Randomised trial comparing low dose vaginal misoprostol and dinoprostone for labour induction. BJOG 2004; 111(1):42–49.
26.
27.
28.
29.
Kim LH, Cheng YW, Delaney S, Jelin AC, Caughey ABI. Preeclampsia associated with an increased risk of cesarean delivery if labor is induced? J Matern Fetal Med. 2010;23(5):383–8.CrossRef
30.
Righetti-Veltema M, Conne-Perréard E, Bousquet A, Manzano J. Risk factors and predictive signs of postpartum depression. J Affect Disord. 1998;49(3):167–80.CrossRefPubMed
Metadata
Title
A comparison of misoprostol vaginal insert and misoprostol vaginal tablets for induction of labor in nulliparous women: a retrospective cohort study
Authors
Kjersti Engen Marsdal
Ingvil Krarup Sørbye
Lise C. Gaudernack
Mirjam Lukasse
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2018
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-017-1647-3

Other articles of this Issue 1/2018

BMC Pregnancy and Childbirth 1/2018 Go to the issue

Research article

Excessive gestational weight gain in accordance with the IOM criteria and the risk of hypertensive disorders of pregnancy: a meta-analysis

Research article

The effect of Kenya’s free maternal health care policy on the utilization of health facility delivery services and maternal and neonatal mortality in public health facilities

Research article

The experience of women with an eating disorder in the perinatal period: a meta-ethnographic study

Research article

Maternal group B Streptococcus recto vaginal colonization increases the odds of stillbirth: evidence from Eastern Ethiopia

Research article

Enablers and barriers to physical activity in overweight and obese pregnant women: an analysis informed by the theoretical domains framework and COM-B model

Research article

Effect of maternal supplement beverage with and without probiotics during pregnancy and lactation on maternal and infant health: a randomized controlled trial in the Philippines